Sigma-1 receptor structure was revealed, leading to potential ALS therapeutic agents
In 2016, Harvard researcher Andrew Kruse first revealed the molecular structure of the sigma-1 receptor, a cellular protein implicated in amyotrophic lateral sclerosis (ALS), which opened the door to potential therapeutic targets.
Tags:
Source: National Library of Medicine
Credit: Image: Andrew Kruse, courtesy Harvard University.
